Literature DB >> 25735664

Carbosilane dendrimers inhibit α-synuclein fibrillation and prevent cells from rotenone-induced damage.

Katarzyna Milowska1, Aleksandra Szwed2, Marta Mutrynowska2, Rafael Gomez-Ramirez3, Francisco Javier de la Mata3, Teresa Gabryelak2, Maria Bryszewska2.   

Abstract

This study investigates the role of carbosilane dendrimers in fibrillation of α-synuclein and prevention of the mouse hippocampal cell (mHippoE-18) from rotenone-induced damage. Examining the interaction between carbosilane dendrimers and α-synuclein, we found that the dendrimers inhibit fibril formation. We also investigated cell viability, the production of reactive oxygen species (ROS), and mitochondrial membrane potential. mHippoE-18 cells were preincubated with carbosilane dendrimers before rotenone was added. All the dendrimers possess potential protection activity. Preincubation with dendrimers contributed to: increased viability, higher mitochondrial membrane potential, and reduced ROS level in cells. The probable mechanism of cell protection lies in the ability of dendrimers to capture rotenone by encapsulating or binding to its surface groups. The fact that dendrimers have prevention potential is important in the search for new pharmacological strategies against neurodegenerative disorders.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carbosilane dendrimers; Parkinson’s disease; Rotenone; α-Synuclein

Mesh:

Substances:

Year:  2015        PMID: 25735664     DOI: 10.1016/j.ijpharm.2015.02.066

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Nanoparticles for drug delivery in Parkinson's disease.

Authors:  Jonathan Baskin; June Evelyn Jeon; Simon J G Lewis
Journal:  J Neurol       Date:  2020-11-03       Impact factor: 4.849

2.  Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells.

Authors:  Sylwia Michlewska; Maksim Ionov; Aleksandra Szwed; Aneta Rogalska; Natalia Sanz Del Olmo; Paula Ortega; Marta Denel; Damian Jacenik; Dzmitry Shcharbin; Francisco Javier de la Mata; Maria Bryszewska
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

Review 3.  Alpha-Synuclein-Nanoparticle Interactions: Understanding, Controlling and Exploiting Conformational Plasticity.

Authors:  Mariapina D'Onofrio; Francesca Munari; Michael Assfalg
Journal:  Molecules       Date:  2020-11-29       Impact factor: 4.411

4.  Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons.

Authors:  Raquel Ferrer-Lorente; Tania Lozano-Cruz; Irene Fernández-Carasa; Katarzyna Miłowska; Francisco Javier de la Mata; Maria Bryszewska; Antonella Consiglio; Paula Ortega; Rafael Gómez; Angel Raya
Journal:  Biomacromolecules       Date:  2021-10-06       Impact factor: 6.988

Review 5.  Dendrimers as Antiamyloid Agents.

Authors:  Svetlana A Sorokina; Zinaida B Shifrina
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

6.  Generation Dependent Effects and Entrance to Mitochondria of Hybrid Dendrimers on Normal and Cancer Neuronal Cells In Vitro.

Authors:  Aleksandra Szwed; Katarzyna Miłowska; Sylwia Michlewska; Silvia Moreno; Dzmitry Shcharbin; Rafael Gomez-Ramirez; Francisco Javier de la Mata; Jean-Pierre Majoral; Maria Bryszewska; Teresa Gabryelak
Journal:  Biomolecules       Date:  2020-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.